梅花生物
(600873)
| 流通市值：284.07亿 | | | 总市值：284.07亿 |
| 流通股本：28.04亿 | | | 总股本：28.04亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 4,543,402,233.92 | 2,913,757,715.41 | 3,015,835,017.01 | 4,561,056,193.96 |
| 交易性金融资产 | 1,975,859,174.33 | 1,397,826,972.26 | 1,947,574,011.81 | 312,033,611.07 |
| 衍生金融资产 | 1,961,200 | 468,200 | 670,200 | - |
| 应收票据及应收账款 | 681,436,041.5 | 700,229,883.25 | 734,446,720.77 | 661,607,013.51 |
| 其中：应收票据 | 111,035,787.13 | 92,822,653.44 | 51,758,511.88 | 73,697,475.3 |
| 应收账款 | 570,400,254.37 | 607,407,229.81 | 682,688,208.89 | 587,909,538.21 |
| 应收款项融资 | 53,509,657.67 | 18,045,534.34 | 30,772,302.09 | 26,723,054.99 |
| 预付款项 | 96,190,131.99 | 107,821,158 | 322,435,573.91 | 220,000,861.75 |
| 其他应收款合计 | 16,164,594.32 | 28,668,079.85 | 19,756,632.66 | 49,292,999.56 |
| 其中:应收利息 | 1,181,250 | 2,362,500 | 1,968,750 | 1,575,000 |
| 应收股利 | 1,395,866.49 | 1,395,866.49 | 1,395,866.49 | 1,395,866.49 |
| 存货 | 2,176,152,704.15 | 2,512,884,223.71 | 3,065,170,465.97 | 2,722,279,908.07 |
| 一年内到期的非流动资产 | 32,618,430.7 | 108,345,222.59 | 215,696,778.22 | 182,257,027.81 |
| 其他流动资产 | 285,015,832.76 | 1,053,547,103.85 | 147,030,689.15 | 164,629,398.67 |
| 流动资产合计 | 9,862,310,001.34 | 8,841,594,093.26 | 9,499,388,391.59 | 8,899,880,069.39 |
| 非流动资产: | | | | |
| 债权投资 | 10,500,000 | 10,500,000 | 10,500,000 | 10,500,000 |
| 长期应收款 | 472,467.45 | 619,712.6 | 605,867.91 | 601,043.91 |
| 长期股权投资 | 4,840,506.23 | 5,951,585.9 | 7,119,939.88 | 6,874,939.88 |
| 其他权益工具投资 | 350,551,760 | 327,534,650 | 348,487,225 | 441,294,280 |
| 其他非流动金融资产 | 300,710,000 | - | - | - |
| 固定资产 | 11,325,954,551.42 | 11,305,605,148.16 | 11,593,103,698.06 | 11,338,208,623.56 |
| 在建工程 | 1,604,241,101.08 | 1,133,239,020.75 | 445,413,073.39 | 728,524,141.54 |
| 使用权资产 | 6,052,460.79 | 5,686,811.92 | 7,238,996.47 | 8,145,892.35 |
| 无形资产 | 1,555,405,260.79 | 1,335,157,587.43 | 1,345,945,854.46 | 1,356,812,266.82 |
| 商誉 | 11,788,911.79 | 11,788,911.79 | 11,788,911.79 | 11,788,911.79 |
| 长期待摊费用 | 141,730,644.21 | 132,143,362.76 | 122,207,227.47 | 122,538,549.51 |
| 递延所得税资产 | 120,520,078.65 | 129,145,474.37 | 113,680,888.39 | 101,814,807.93 |
| 其他非流动资产 | 696,262,159.35 | 762,531,174.19 | 791,378,399.16 | 782,574,484.98 |
| 非流动资产合计 | 16,129,029,901.76 | 15,159,903,439.87 | 14,797,470,081.98 | 14,909,677,942.27 |
| 资产总计 | 25,991,339,903.1 | 24,001,497,533.13 | 24,296,858,473.57 | 23,809,558,011.66 |
| 流动负债: | | | | |
| 短期借款 | 1,834,996,073.76 | 1,586,838,913.18 | 1,682,300,239.99 | 1,734,832,631.06 |
| 衍生金融负债 | - | - | 99,600 | 297,500 |
| 应付票据及应付账款 | 3,383,550,154.65 | 3,000,809,893.71 | 2,744,688,982.67 | 2,857,750,606.68 |
| 其中：应付票据 | 1,712,756,037.72 | 1,423,949,868.69 | 1,274,734,112.07 | 1,416,217,579.96 |
| 应付账款 | 1,670,794,116.93 | 1,576,860,025.02 | 1,469,954,870.6 | 1,441,533,026.72 |
| 合同负债 | 949,096,044 | 656,660,453.8 | 704,476,996.09 | 916,515,321.35 |
| 应付职工薪酬 | 416,796,293.13 | 337,442,819.61 | 303,661,585.19 | 310,133,688.99 |
| 应交税费 | 300,652,332.96 | 250,775,388.2 | 325,380,565.13 | 280,212,685.6 |
| 其他应付款合计 | 261,321,008.74 | 242,540,793.08 | 248,621,093.28 | 448,115,137.98 |
| 应付股利 | 405,000 | 405,000 | 409,445.58 | 409,445.58 |
| 一年内到期的非流动负债 | 373,437,753.7 | 710,617,924.83 | 924,520,213.64 | 802,346,793.78 |
| 其他流动负债 | 126,632,613.62 | 61,495,237.41 | 57,540,051.8 | 88,785,123.74 |
| 流动负债合计 | 7,646,482,274.56 | 6,847,181,423.82 | 6,991,289,327.79 | 7,438,989,489.18 |
| 非流动负债: | | | | |
| 长期借款 | 1,821,343,675.44 | 1,732,115,654.12 | 1,412,761,764.93 | 1,348,094,044.83 |
| 租赁负债 | 1,854,550.76 | 1,557,058.76 | 1,751,984.98 | 1,985,140.84 |
| 长期应付款 | 10,500,000.2 | 10,500,000 | 10,500,000 | 10,500,000 |
| 长期应付职工薪酬 | 6,514,442.65 | - | - | - |
| 预计负债 | 3,829,175.05 | 32,948,103.32 | 32,691,723.94 | 32,438,161.92 |
| 递延收益 | 364,444,376.75 | 375,510,410.61 | 374,678,509.41 | 381,020,645.51 |
| 递延所得税负债 | 20,536,638.24 | 21,550,168.28 | 21,722,813.35 | 21,585,228.45 |
| 非流动负债合计 | 2,229,022,859.09 | 2,174,181,395.09 | 1,854,106,796.61 | 1,795,623,221.55 |
| 负债合计 | 9,875,505,133.65 | 9,021,362,818.91 | 8,845,396,124.4 | 9,234,612,710.73 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,804,241,650 | 2,852,788,750 | 2,852,788,750 | 2,852,788,750 |
| 资本公积 | 33,749,867.59 | 263,154,867.05 | 263,154,867.05 | 263,154,867.05 |
| 减:库存股 | - | 352,066,338.78 | 352,066,338.78 | 287,771,455.8 |
| 其他综合收益 | -135,107,124.62 | -153,671,324.15 | -133,905,315.41 | -55,004,961.46 |
| 专项储备 | 4,931,483.03 | 4,931,483.03 | 5,749,534.39 | 4,743,615.67 |
| 盈余公积 | 1,212,273,753.22 | 1,426,394,375 | 1,426,394,375 | 1,426,394,375 |
| 未分配利润 | 12,195,745,140.23 | 10,938,602,902.07 | 11,389,346,476.92 | 10,370,640,110.47 |
| 归属于母公司股东权益合计 | 16,115,834,769.45 | 14,980,134,714.22 | 15,451,462,349.17 | 14,574,945,300.93 |
| 股东权益合计 | 16,115,834,769.45 | 14,980,134,714.22 | 15,451,462,349.17 | 14,574,945,300.93 |
| 负债和股东权益合计 | 25,991,339,903.1 | 24,001,497,533.13 | 24,296,858,473.57 | 23,809,558,011.66 |
| 公告日期 | 2025-10-30 | 2025-08-20 | 2025-04-22 | 2025-03-18 |
| 审计意见(境内) | | | | 标准无保留意见 |